Evaluation of the ceftazidime/avibactam and meropenem susceptibility by MALDI-TOF MS directly from positive blood cultures-Reference-Cited by-同舟云学术

Evaluation of the ceftazidime/avibactam and meropenem susceptibility by MALDI-TOF MS directly from positive blood cultures

Published:2023-11-07 Issue:1 Volume:43 Page:171-175
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Wilhelm Camila Mörschbächer^ORCID,Moreira Natália Kehl,Inamine Everton,Caierão Juliana,Barth Afonso Luís

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10096-023-04696-5.pdf

Reference18 articles.

1. Xu L, Sun X, Ma X (2017) Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob 16:1–12. https://doi.org/10.1186/s12941-017-0191-3

2. Bonomo RA, Burd EM, Conly J et al (2018) Carbapenemase-producing organisms: a global scourge. Clin Infect Dis 66:1290–1297. https://doi.org/10.1093/cid/cix893

3. Wink PL, Martins AS, Volpato F et al (2021) Increased frequency of bla NDM in a tertiary care hospital in southern Brazil. Braz J Microbiol 52:299–301. https://doi.org/10.1007/s42770-020-00412-z/Published

4. European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2017) EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. Version 2.0. https://www.eucast.org/. Accessed 30 Jun 2022

5. Wang Y, Wang J, Wang R, Cai Y (2020) Resistance to ceftazidime-avibactam and underlying mechanisms. J Glob Antimicrob Resist 22:18–27. https://doi.org/10.1016/j.jgar.2019.12.009